Joseph D’Souza

1.2k total citations
26 papers, 788 citations indexed

About

Joseph D’Souza is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Joseph D’Souza has authored 26 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 16 papers in Pediatrics, Perinatology and Child Health and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Joseph D’Souza's work include Epilepsy research and treatment (16 papers), Pharmacological Effects and Toxicity Studies (16 papers) and Neuroscience and Neuropharmacology Research (9 papers). Joseph D’Souza is often cited by papers focused on Epilepsy research and treatment (16 papers), Pharmacological Effects and Toxicity Studies (16 papers) and Neuroscience and Neuropharmacology Research (9 papers). Joseph D’Souza collaborates with scholars based in United States, Canada and Belgium. Joseph D’Souza's co-authors include Ahmad Beydoun, David Hébert, Pamela Doty, Rǎjesh C. Sachdeo, Ekrem Kutluay, Stephen L. Yates, Toufic Fakhoury, Wei Liang, Simon Borghs and Klaus Eckhardt and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Annals of Neurology.

In The Last Decade

Joseph D’Souza

26 papers receiving 740 citations

Peers

Countries citing papers authored by Joseph D’Souza

Since Specialization

Citations

This map shows the geographic impact of Joseph D’Souza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph D’Souza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph D’Souza more than expected).

Fields of papers citing papers by Joseph D’Souza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph D’Souza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph D’Souza. The network helps show where Joseph D’Souza may publish in the future.

Co-authorship network of co-authors of Joseph D’Souza

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph D’Souza. A scholar is included among the top collaborators of Joseph D’Souza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph D’Souza. Joseph D’Souza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Density Based Traffic Control System 2020 ·Journal of Emerging Technologies and Innovative Research ·Joseph D’Souza, (unknown), (unknown), (unknown), (unknown), (unknown)	1
2	<p>Patient and physician perceptions of disease management in Parkinson’s disease: results from a US-based multicenter survey</p> 2019 ·Neuropsychiatric Disease and Treatment ·Neal Hermanowicz, (unknown), (unknown), Jesse Fishman, Joseph D’Souza	8
3	Evaluation of brivaracetam efficacy as monotherapy in adult patients with focal seizures 2017 ·Epilepsy Research ·Rik C. Schoemaker, Janet R. Wade, Joseph D’Souza, Armel Stockis	12
4	Tolerability, safety, and efficacy of adjunctive brivaracetam for focal seizures in older patients: A pooled analysis from three phase III studies 2016 ·Epilepsy Research ·Martin J. Brodie, John Whitesides, Jimmy Schiemann, Joseph D’Souza, Martin Johnson	29
5	Brivaracetam (BRV) Achieves Brain SV2A Occupancy Faster than Levetiracetam (LEV) (S22.003) 2015 ·Neurology ·Joël Mercier, Daniel Holden, Anand K. Deo, Krista Fowles, Sophie Kervyn, Nabeel Nabulsi, Jean‐Marie Nicolas, Henrik Klitgaard, Yiyun Huang, Joseph D’Souza, Richard E. Carson, Jonas Hannestad	2
6	An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam 2015 ·Epilepsy & Behavior ·Stephen L. Yates, Toufic Fakhoury, Wei Liang, Klaus Eckhardt, Simon Borghs, Joseph D’Souza	121
7	Clinical features associated with placebo response in refractory focal epilepsy 2013 ·Epilepsy & Behavior ·Dieter Schmidt, Stefan Beyenburg, Joseph D’Souza, Knut Stavem	19
8	Changes in erosional and depositional processes with time and management of Goa Coast, central west coast of India 2010 ·EGUGA ·G. N. Nayak, Joseph D’Souza	1
9	Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures 2008 ·Expert Review of Neurotherapeutics ·Ahmad Beydoun, Joseph D’Souza, David Hébert, Pamela Doty	118
10	A Double-Blind, Randomized, Placebo-Controlled Trial of Oxcarbazepine in the Treatment of Bipolar Disorder in Children and Adolescents 2006 ·American Journal of Psychiatry ·Karen Dineen Wagner, Robert A. Kowatch, Graham J. Emslie, Robert L. Findling, Timothy E. Wilens, (unknown), Joseph D’Souza, Artur W. Wamil, (unknown), Douglas A. Berv, David E.J. Linden	120
11	Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy 2006 ·Epilepsy & Behavior ·Rǎjesh C. Sachdeo, John R. Gates, Carl W. Bazil, Gregory L. Barkley, William O. Tatum, Joseph D’Souza, (unknown)	15
12	Efficacy, safety, and tolerability of oxcarbazepine monotherapy 2006 ·Epilepsy & Behavior ·Walter Martínez, (unknown), (unknown), Gregory L. Barkley, (unknown), Joseph D’Souza	21
13	A cost comparison of alternative regimens fortreatment-refractory partial seizure disorder: An econometric analysis 2005 ·Clinical Therapeutics ·Won Chan Lee, Marc Hoffmann, Steve Arcona, Joseph D’Souza, Qin Wang, Chris L. Pashos	8
14	Long-term safety and tolerability of oxcarbazepine in children: A review of clinical experience 2005 ·Epilepsy & Behavior ·Blaise F. D. Bourgeois, Joseph D’Souza	17
15	Oxcarbazepine Pharmacokinetics and Tolerability in Children With Inadequately Controlled Epilepsy 2004 ·The Journal of Clinical Pharmacology ·Elisabeth Rey, Christine Bulteau, Jacques Motté, Agnès Tran, Y. Sturm, Joseph D’Souza, S. Markabi, Gérard Pons, Olivier Dulac	33
16	Safety and tolerability of oxcarbazepine in elderly patients with epilepsy 2003 ·Epilepsy & Behavior ·Ekrem Kutluay, (unknown), Joseph D’Souza, Ahmad Beydoun	67
17	Sustained Efficacy and Long‐term Safety of Oxcarbazepine: One‐year Open‐label Extension of a Study in Refractory Partial Epilepsy 2003 ·Epilepsia ·Ahmad Beydoun, Rǎjesh C. Sachdeo, Ekrem Kutluay, (unknown), Joseph D’Souza	29
18	Effects of oxcarbazepine on sodium concentration and water handling 2002 ·Annals of Neurology ·Rǎjesh C. Sachdeo, Alan G. Wasserstein, (unknown), Joseph D’Souza	66
19	Effect of a new nootropic agent, CGS 5649B, on cognition, function, and behavior in dementia 1993 ·Journal of General Internal Medicine ·D. William Molloy, (unknown), Timothy I. Standish, Andrew R. Willan, William E. McIlroy, Joseph D’Souza, Gregory S. Brown, (unknown)	5
20	Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man 1985 ·Digestive Diseases and Sciences ·Max M. Cohen, (unknown), (unknown), Joseph D’Souza	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact